1. Home
  2. DOOO vs APLS Comparison

DOOO vs APLS Comparison

Compare DOOO & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BRP Inc.

DOOO

BRP Inc.

HOLD

Current Price

$76.66

Market Cap

4.6B

Sector

N/A

ML Signal

HOLD

Logo Apellis Pharmaceuticals Inc.

APLS

Apellis Pharmaceuticals Inc.

HOLD

Current Price

$25.03

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOOO
APLS
Founded
1937
2009
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
2.7B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
DOOO
APLS
Price
$76.66
$25.03
Analyst Decision
Buy
Buy
Analyst Count
6
19
Target Price
$77.40
$33.11
AVG Volume (30 Days)
183.2K
2.2M
Earning Date
12-04-2025
10-30-2025
Dividend Yield
0.80%
N/A
EPS Growth
N/A
N/A
EPS
0.24
0.36
Revenue
$5,730,422,869.00
$1,016,397,000.00
Revenue This Year
$6.06
$29.00
Revenue Next Year
$6.25
N/A
P/E Ratio
$322.50
$70.45
Revenue Growth
N/A
42.11
52 Week Low
$31.78
$16.10
52 Week High
$78.07
$35.71

Technical Indicators

Market Signals
Indicator
DOOO
APLS
Relative Strength Index (RSI) 79.85 67.89
Support Level $68.61 $23.54
Resistance Level $78.07 $25.52
Average True Range (ATR) 2.33 0.92
MACD 1.20 0.61
Stochastic Oscillator 91.82 92.36

Price Performance

Historical Comparison
DOOO
APLS

About DOOO BRP Inc.

BRP designs, develops, manufactures, distributes, and markets snowmobiles, all-terrain vehicles, and personal watercraft under the Ski-Doo, Sea-Doo, Can-Am, and Lynx brand names. It also builds engines under the Rotax brand (after shuttering the Evinrude outboard engine business in 2020) and offers clothing, parts, and accessories that cater to its core consumers. In 2018, BRP created a marine group, which has largely been divested (Manitou pontoon boats sale is set to close in the third quarter). At the end of fiscal 2025, the company sold its products through a network of more than 2,400 independent dealers and 140 distributors in around 130 countries.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: